Analytical Data
-
基因名
CYSRT1
- Application
-
别名
CYSRT1；C9orf169；Cysteine-rich tail Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
B8A4K4
-
表达区间
1-184aa
-
氨基酸序列
MAPPLPRREKAAASRSTQALGPRAQKTERTDCRVATTGWTMDPQEMVVKNPYAHISIPRAHLRPDLGQQLEVASTCSSSSEMQPLPVGPCAPEPTHLLQPTEVPGPKGAKGNQGAAPIQNQQAWQQPGNPYSSSQRQAGLTYAGPPPAGRGDDIAHHCCCCPCCHCCHCPPFCRCHSCCCCVIS
-
分子量
25.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CYSRT1 is a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family, which plays a crucial role in cell-cell interactions and immune response modulation. Research into CYSRT1 has gained momentum due to its potential implications in various pathological conditions, including autoimmune disorders and cancer. The protein is characterized by its ability to bind sialic acids, which are often present on the surface of glycoproteins and glycolipids, influencing cellular signaling pathways. This interaction can lead to the regulation of immune responses, making CYSRT1 a compelling target for therapeutic interventions. Additionally, studies suggest that altered expression of CYSRT1 may be linked to the progression of certain diseases, highlighting its significance in both basic and translational research. By generating recombinant CYSRT1 proteins, researchers aim to delve deeper into its functional mechanisms and explore its potential as a biomarker or therapeutic target, contributing to the development of novel treatments for a range of diseases. The growing interest in CYSRT1 underscores the necessity for a comprehensive understanding of its role in physiology and pathology, paving the way for innovative approaches in disease management.
